(Q39557608)
Statements
Inhibition of c-ABL sensitizes breast cancer cells to the dual ErbB receptor tyrosine kinase inhibitor lapatinib (GW572016) (English)
Yuan-Hung Lo
Po-Chun Ho
Huajun Zhao
Shao-Chun Wang
scientific article published on March 2011